Gene Therapy in Ophthalmology
Gene therapy in ophthalmology represents a cutting-edge approach aimed at treating inherited and acquired eye diseases at the genetic level. This innovative technique involves delivering therapeutic genes into target cells of the eye using viral vectors or other delivery systems. By correcting genetic mutations or introducing beneficial genes, gene therapy holds promise for conditions such as retinal dystrophies, inherited retinal diseases, and even some forms of glaucoma. Clinical trials have shown encouraging results, with potential benefits including improved visual function and slowed disease progression. Ongoing research focuses on optimizing delivery methods, enhancing safety profiles, and expanding treatment options for a broader range of ocular disorders.